Pfizer Inc To Split Generic, Branded Drugs Units-Reuters

Monday, 29 Jul 2013 01:46pm EDT 

Reuters reported that Pfizer Inc, in what could be the prelude to spinning off its generics drug business, said it plans to separate its commercial operations into two units, mainly for patent-protected brands and a third for generics. Pfizer, said on July 29, 2013 the changes will take effect by January in countries that do not require a consultation with labor unions. The business represents 17% of total sales and overwhelmingly comes from overseas. Baum and Fernandez said any spin-off of a company division would be unlikely before 2016, after Pfizer completes its examination. 

Company Quote

-0.66 -0.82%
27 Feb 2015